Ubs Group Ag Cullinan Oncology, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 185,553 shares of CGEM stock, worth $2.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

185,553

Previous 159,980 15.99%

Holding current value

$2.5 Million

Previous $2.79 Million 11.33%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$16.03 - $20.86 $409,935 - $533,452	25,573 Added 15.99%	185,553 $3.11 Million
Q2 2024 Aug 13, 2024	SELL	$15.63 - $29.35 $105,658 - $198,406	-6,760 Reduced 4.05%	159,980 $2.79 Million
Q1 2024 May 13, 2024	BUY	$10.17 - $19.02 $264,023 - $493,778	25,961 Added 18.44%	166,740 $2.84 Million
Q4 2023 Feb 09, 2024	BUY	$7.89 - $10.23 $294,423 - $381,742	37,316 Added 36.07%	140,779 $1.43 Million
Q3 2023 Nov 09, 2023	BUY	$9.05 - $11.72 $112,183 - $145,281	12,396 Added 13.61%	103,463 $936,000
Q2 2023 Aug 11, 2023	SELL	$8.8 - $13.4 $87,868 - $133,799	-9,985 Reduced 9.88%	91,067 $979,000
Q1 2023 May 12, 2023	BUY	$10.2 - $11.91 $29,569 - $34,527	2,899 Added 2.95%	101,052 $1.03 Million
Q4 2022 Feb 08, 2023	BUY	$9.72 - $13.62 $68,875 - $96,511	7,086 Added 7.78%	98,153 $1.04 Million
Q3 2022 Nov 10, 2022	SELL	$11.82 - $15.42 $8,380 - $10,932	-709 Reduced 0.77%	91,067 $1.17 Million
Q2 2022 Aug 10, 2022	SELL	$7.31 - $13.55 $242,202 - $448,952	-33,133 Reduced 26.53%	91,776 $1.18 Million
Q1 2022 May 16, 2022	BUY	$10.47 - $16.75 $1.08 Million - $1.73 Million	103,167 Added 474.51%	124,909 $1.31 Million
Q4 2021 Feb 14, 2022	BUY	$15.36 - $25.0 $272,624 - $443,725	17,749 Added 444.5%	21,742 $336,000
Q3 2021 Nov 15, 2021	BUY	$22.56 - $29.68 $45,729 - $60,161	2,027 Added 103.1%	3,993 $90,000
Q2 2021 Aug 13, 2021	SELL	$24.96 - $41.25 $28,129 - $46,488	-1,127 Reduced 36.44%	1,966 $50,000
Q1 2021 May 12, 2021	BUY	$28.0 - $53.42 $86,604 - $165,228	3,093 New	3,093 $129,000

Others Institutions Holding CGEM

# of Institutions

146

Shares Held

67.6M

Call Options Held

612K

Put Options Held

118K

View Full List

About Cullinan Oncology, Inc.

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $613M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

More about CGEM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account